Polybenzimidazole and its preparation method and application

By designing polybenzimidazoles with allyl structures and using specific preparation methods, the problems of difficult melting and processing of polybenzimidazole resins are solved, and their easy processing ability in high temperature occasions and material modification are achieved. Its application scope.

CN115490859BActive Publication Date: 2024-12-06CHINA PETROLEUM & CHEMICAL CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110680243.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-06-18
Publication Date
2024-12-06
Estimated Expiration
2041-06-18

AI Technical Summary

Technical Problem

The existing polybenzimidazole resins have high preparation temperatures, are difficult to melt and process, which limits their application range, especially in high temperature occasions and material modifications.

Method used

A polybenzimidazole containing an allyl structure was designed, and a compound containing a tetraamine group and a compound containing a diacid group was reacted in a polyphosphoric acid solution under protective gas conditions to prepare easy dissolution. polybenzimidazole and subsequent chemical modification through allyl structure to expand its application range.

Benefits of technology

It realizes easy dissolution processing of polybenzimidazole, expanding its application scope, especially in the fields of aerospace, semiconductors, fire-resistant and heat-resistant materials and fuel cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115490859B_ABST
    Figure CN115490859B_ABST
Patent Text Reader

Abstract

The present invention relates to a polybenzimidazole, comprising a repeating unit structure shown in formula I: #imgabs0# The polybenzimidazole of the present invention contains an allyl structure that can undergo further modification reactions and is easy to dissolve. The allyl structure can undergo subsequent chemical modification reactions and introduce other functional groups, thereby expanding the application scope of the polybenzimidazole.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of polymer synthesis, and specifically relates to polybenzimidazole and a preparation method and application thereof. Background Art

[0002] Polybenzimidazole (PBI) is a type of aromatic heterocyclic polymer with a repeating benzimidazole ring structure unit in the main chain. It is mainly prepared by the condensation of aromatic dicarboxylic acids and tetraamine monomers. It was first reported in 1961 and synthesized by Vogel and Marvel. Fully aromatic polybenzimidazole resin has good heat resistance and excellent mechanical properties. It is a special engineering plastic with excellent performance and is widely used in high-tech fields such as aerospace, semiconductors, fireproof and heat-resistant materials, and fuel cells. Commercial polybenzimidazole resin (poly [2,2'-(m-phenylene)-5,5'-dibenzimidazole], mPBI) has a high heat resistance temperature, instantaneous heat resistance can reach above 700°C, high strength, and can be used in a variety of extreme high temperature occasions. However, the preparation temperature of poly[2,2'-(meta-phenylene)-5,5'-dibenzimidazole] resin is high (above 200°C), and it is difficult to melt and process. The film-forming process has high requirements on the experimental equipment and harsh operating conditions. The prepared polybenzimidazole film material is difficult to modify, which brings difficulties to its further application.

[0003] Therefore, it is urgent to study a polybenzimidazole that is easy to dissolve and process, so as to expand its application range. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a polybenzimidazole that is easy to dissolve and process and can be further modified subsequently, so as to expand its application range.

[0005] In a first aspect, the present invention provides a polybenzimidazole comprising a repeating unit structure shown in formula I:

[0006]

[0007] Wherein, R is selected from any one of Formula II or Formula III:

[0008]

[0009] X is selected from any one of formula (1) to formula (7):

[0010]

[0011] The R2 part is all or selected from any one of Formula IV to Formula I:

[0012]

[0013] R and R2 may be the same or different along the molecular chain.

[0014] As a specific embodiment of the present invention, the polybenzimidazole has a number average molecular weight of 2000 g / mol to 800000 g / mol, for example, 2000 g / mol, 5000 g / mol, 8000 g / mol, 10000 g / mol, 50000 g / mol, 100000 g / mol, 200000 g / mol, 300000 g / mol, 400000 g / mol, 500000 g / mol, 600000 g / mol, 700000 g / mol, 800000 g / mol and any combination thereof.

[0015] Unless otherwise specified, the raw materials in the present invention can be prepared in-house or commercially available, and the present invention is not particularly limited thereto.

[0016] The polybenzimidazole of the present invention contains an allyl structure that can undergo further modification reactions and is easy to dissolve. The allyl structure can undergo subsequent chemical modification reactions and introduce other functional groups, thereby expanding the application range of the polybenzimidazole.

[0017] In a second aspect, the present invention provides a method for preparing the polybenzimidazole, comprising the following steps:

[0018] Under protective gas conditions, a compound containing a tetraamine group and a compound containing a diacid group are dissolved in a clear solution containing polyphosphoric acid at a molar ratio of (0.8:1) to (1:1.2), heated to 160° C. to 220° C. for reaction for 1 h to 48 h, then washed to neutrality, filtered, the filter residue is collected and then dried to obtain the polybenzimidazole.

[0019] As a specific embodiment of the present invention, the sum of the mass of the tetraamine group-containing compound and the diacid group-containing compound accounts for 1% to 20% of the clear solution, for example, 1%, 5%, 15%, 20% and any combination thereof.

[0020] As a specific embodiment of the present invention, the molar ratio of the compound containing tetraamine groups to the compound containing diacid groups is preferably (1.02:1) to (1:1.02), for example, 1:1, 1.02:1, 1:1.02 and any combination thereof.

[0021] As a specific embodiment of the present invention, the clear solution containing polyphosphoric acid further includes phosphorus pentoxide. Preferably, the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15), more preferably 1:(8-13), for example, 1:8, 1:10, 1:13 and any combination thereof.

[0022] As a specific embodiment of the present invention, the tetraamino group-containing compound is selected from any one of Formula II' or Formula III':

[0023]

[0024] Wherein, X is selected from any one of formula (1) to formula (7):

[0025]

[0026] As a specific embodiment of the present invention, the compound containing a diacid group is selected in whole or in part from any one of Formula IV' to Formula I':

[0027]

[0028] As a specific embodiment of the present invention, the compound containing diacid groups is prepared by dissolving a compound containing hydroxydiacid groups and a halogenated hydrocarbon in a solvent and refluxing for 2h to 24h, for example, 2h, 8h, 16h, 24h and any combination thereof.

[0029] As a specific embodiment of the present invention, the compound containing a hydroxy diacid group is selected from any one of Formula IV" to Formula VIII":

[0030]

[0031] As a specific embodiment of the present invention, the halogenated hydrocarbon has the formula Structure, wherein Z is selected from any one of F, Cl, Br, and I.

[0032] As a specific embodiment of the present invention, the solvent is selected from one or more of tetrahydrofuran, acetone, ethanol, acetonitrile, N-methylpyrrolidone, dimethyl sulfoxide, N'N-dimethylformamide and N,N-dimethylacetamide.

[0033] As a specific embodiment of the present invention, the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15), preferably 1:(8-13).

[0034] As a specific embodiment of the present invention, a saturated sodium bicarbonate aqueous solution, a saturated potassium carbonate aqueous solution, a saturated sodium carbonate aqueous solution or ammonia water is used for the washing operation.

[0035] As a specific embodiment of the present invention, the purpose of drying is mainly to remove the solvent, and the drying method can adopt a conventional method in the art, and the present invention does not specifically limit this. The drying temperature can be 80°C to 100°C, for example, 80°C, 90°C, 100°C and any combination thereof, and the drying temperature can be adjusted according to the drying time.

[0036] As a specific implementation of the present invention, the protective gas is nitrogen.

[0037] In a third aspect, the present invention provides another method for preparing polybenzimidazole.

[0038] The preparation method of polybenzimidazole comprises the following steps:

[0039] S101: Under protective gas conditions, dissolving a tetraamine group-containing compound and a hydroxydiacid group-containing compound in the clear solution at a molar ratio of (0.8:1) to (1:1.2), heating to 160° C. to 220° C. for reaction for 1 h to 48 h, then washing to neutrality, filtering and collecting the filter residue, and then drying to obtain a polybenzimidazole intermediate;

[0040] S102: dissolving the polybenzimidazole intermediate and halogenated hydrocarbon in a solvent, and refluxing for 2 h to 24 h to prepare the polybenzimidazole intermediate.

[0041] As a specific embodiment of the present invention, the clear solution containing polyphosphoric acid further includes phosphorus pentoxide. Preferably, the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15), more preferably 1:(8-13), for example, 1:8, 1:10, 1:13 and any combination thereof.

[0042] As a specific embodiment of the present invention, the sum of the mass of the compound containing tetraamine groups and the compound containing hydroxydiacid groups accounts for 1% to 20% of the clear solution.

[0043] As a specific embodiment of the present invention, the molar ratio of the compound containing tetraamine groups to the compound containing hydroxydiacid groups can be (1.02:1) to (1:1.02), for example, 1:1, 1.02:1, 1:1.02 and any combination thereof.

[0044] As a specific embodiment of the present invention, the tetraamino group-containing compound is selected from any one of Formula II' or Formula III':

[0045]

[0046] Wherein, X is selected from any one of formula (1) to formula (7):

[0047]

[0048] As a specific embodiment of the present invention, the compound containing a hydroxy diacid group is selected in whole or in part from any one of Formula IV" to Formula VIII":

[0049]

[0050] As a specific embodiment of the present invention, the halogenated hydrocarbon has the formula Structure, wherein Z is selected from any one of F, Cl, Br, and I.

[0051] As a specific embodiment of the present invention, the solvent is selected from one or more of tetrahydrofuran, acetone, ethanol, N'N-dimethylformamide and N,N-dimethylacetamide.

[0052] As a specific embodiment of the present invention, the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15), preferably 1:(8-13).

[0053] As a specific embodiment of the present invention, in step S101, a saturated sodium bicarbonate aqueous solution, a saturated potassium carbonate aqueous solution, a saturated sodium carbonate aqueous solution or ammonia water is used for washing.

[0054] As a specific embodiment of the present invention, in the step S101, the purpose of drying is mainly to remove the solvent, and the drying method can adopt conventional methods in the art, and the present invention does not specifically limit this. The drying temperature can be 80°C to 100°C, for example, 80°C, 90°C, 100°C and any combination thereof, and the drying temperature can be adjusted according to the drying time.

[0055] As a specific implementation of the present invention, in the step S101, the protective gas is nitrogen.

[0056] In a fourth aspect, the present invention proposes the application of the polybenzimidazole and / or the method for preparing the polybenzimidazole in the fields of aerospace materials, semiconductor materials, fireproof and heat-resistant materials, and fuel cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] The present invention will be further described in detail below in conjunction with the accompanying drawings.

[0058] Figure 1 is the H NMR spectrum of the polybenzimidazole intermediate of Example 1;

[0059] Figure 2 is the H NMR spectrum of Vinyl-O-PBI;

[0060] Figure 3 is the NMR spectrum of co-OH-PBI;

[0061] Figure 4 This is the H NMR spectrum of Vinyl-co-PBI-2. DETAILED DESCRIPTION

[0062] In order to make the present invention easier to understand, the present invention will be described in detail below with reference to embodiments and drawings. These embodiments are only for illustration and are not intended to limit the application scope of the present invention.

[0063] The test methods or standards used in the following examples and comparative examples are as follows:

[0064] Nuclear magnetic resonance hydrogen spectrum: Agilent Technologies, USA, instrument model is 400-MR DD2, 1H resonance frequency is 399.87MHz. The solvent is deuterated sulfuric acid, and the test temperature is 50℃. The hydrogen spectrum uses a 45° pulse, a cycle delay time of 5s, and a sampling time of 2s.

[0065] The sources of materials for the following examples are as follows:

[0066]

[0067]

[0068] [Example 1]

[0069] Weigh phosphorus pentoxide (6 g) and dissolve it in polyphosphoric acid (60 g) to form a clear solution. Add 2,5-dihydroxyterephthalic acid (10 mmol) and 3,3-diaminobenzidine (10 mmol) under nitrogen and heat to 200°C under stirring for 3 hours. Pour the reaction solution into saturated sodium bicarbonate and wash until neutral, filter, and place the polybenzimidazole intermediate (OH-PBI) in a vacuum oven at 80°C for one day and night.

[0070] OH-PBI:

[0071] Its hydrogen nuclear magnetic spectrum is as follows Figure 1 shown.

[0072] Weigh polybenzimidazole intermediate (OH-PBI, 10 mmol), allyl bromide (40 mol), potassium carbonate (2 mmol) and tetrabutylammonium bromide (2 mmol) in 50 ml of acetonitrile, stir at 80°C for 1 day and night, filter, and remove the solvent by rotary evaporation to obtain Vinyl-O-PBI.

[0073] Vinyl-O-PBI:

[0074] Its H NMR spectrum is as follows Figure 2 As shown:

[0075] H 1 NMR (Vinyl-O-PBI, 400 MHz, d 2 -H2SO4): δ7.69(m,6H),7.44(d,2H),4.16(s,2H),3.02(d,3H),2.13(s,2H).

[0076] [Example 2]

[0077] Weigh 2,5-dihydroxyterephthalic acid (20 mmol), allyl bromide (40 mol), potassium carbonate (2 mmol) and tetrabutylammonium bromide (2 mmol) in 10 ml of tetrahydrofuran, stir at room temperature for 1 day and night, filter, and remove the solvent by rotary evaporation to obtain VDA (its structure is shown below):

[0078]

[0079] Weigh phosphorus pentoxide (6 g) and dissolve it in polyphosphoric acid (60 g) to form a clear solution. Add VDA (10 mmol) and 3,3-diaminobenzidine (10 mmol) under nitrogen and heat to 200°C with stirring for 10 hours. Pour the reaction solution into saturated sodium bicarbonate and wash until neutral, filter, and place the product (Vinyl-O-PBI) in a vacuum oven at 80°C for one day and night.

[0080] Vinyl-O-PBI:

[0081] Its H NMR spectrum (such as Figure 2 )show:

[0082] H 1 NMR (Vinyl-O-PBI, 400 MHz, d 2 -H2SO4): δ7.69(m,6H),7.44(d,2H),4.16(s,2H),3.02(d,3H),2.13(s,2H).

[0083] [Example 3]

[0084] The preparation method of VDA is the same as Example 2.

[0085] Weigh phosphorus pentoxide (6 g) and dissolve it in polyphosphoric acid (60 g) to form a clear solution. Add VDA (1 mmol), 2,5-dihydroxyterephthalic acid (9 mmol) and 3,3-diaminobenzidine (10 mmol) under nitrogen and heat to 200°C under stirring for 10 hours. Pour the reaction solution into saturated sodium bicarbonate and wash until neutral, filter, and place the product (Vinyl-co-PBI) in a vacuum oven at 80°C for one day and night.

[0086] Structure of Vinyl-co-PBI:

[0087]

[0088] [Example 4]

[0089] Weigh polyphosphoric acid (70 g), add 2,5-dihydroxyterephthalic acid (1 mmol), 4,4-dicarboxy diphenyl ether (9 mmol) and 3,3-diaminobenzidine (10 mmol) under nitrogen and heat to 190°C under stirring for 3 hours. Pour the reaction solution into saturated sodium bicarbonate, wash until neutral, filter, and keep the intermediate product (co-OH-PBI) in a vacuum oven at 80°C for one day and night.

[0090] Structure of co-OH-PBI:

[0091]

[0092] Its NMR spectrum is as follows Figure 3 shown.

[0093] Weigh polybenzimidazole intermediate (co-OH-PBI, 10 mmol), allyl bromide (20 mol), potassium carbonate (2 mmol) and tetrabutylammonium bromide (2 mmol) in 100 ml DMAc, stir at 80°C for 1 day and night, filter, and remove the solvent by rotary evaporation to obtain Vinyl-co-PBI-2.

[0094] The structure of Vinyl-co-PBI-2 is as follows:

[0095]

[0096] Its H NMR spectrum is as follows Figure 4 shown.

[0097] It should be noted that the embodiments described above are only used to explain the present invention and do not constitute any limitation to the present invention. The present invention has been described with reference to typical embodiments, but it should be understood that the words used therein are descriptive and explanatory words, rather than restrictive words. The present invention may be modified as specified within the scope of the claims of the present invention, and the present invention may be revised without departing from the scope and spirit of the present invention. Although the present invention described therein relates to specific methods, materials and embodiments, it does not mean that the present invention is limited to the specific examples disclosed therein, on the contrary, the present invention can be extended to all other methods and applications with the same functions.

Claims

1. A polybenzimidazole, characterized in that: Comprising a repeating unit structure shown in formula I: Wherein, R is selected from Formula II: R2 is partially or completely selected from any one of the following: R and R2 are the same or different along the molecular chain; The number average molecular weight of the polybenzimidazole is 2000 g / mol to 800000 g / mol.

2. The method for preparing the polybenzimidazole according to claim 1, characterized in that: The method comprises the following steps: under protective gas conditions, dissolving a tetraamine group-containing compound and a diacid group-containing compound in a clear solution containing polyphosphoric acid at a molar ratio of (0.8:1) to (1:1.2), heating to 160° C. to 220° C. for reaction for 1 h to 48 h, then washing to neutrality, filtering and collecting the filter residue, and then drying to obtain the polybenzimidazole; Wherein, the compound containing tetraamino group is selected from formula II': The compound containing a diacid group is selected in whole or in part from any one of the following:

3. The method for preparing polybenzimidazole according to claim 2, characterized in that: The sum of the mass of the tetraamine group-containing compound and the diacid group-containing compound accounts for 1% to 20% of the clear solution, and / or the molar ratio of the tetraamine group-containing compound to the diacid group-containing compound is (1.02:1) to (1:1.02).

4. The method for preparing polybenzimidazole according to claim 2, characterized in that: The compound containing a diacid group is prepared by dissolving a compound containing a hydroxy diacid group and a halogenated hydrocarbon in a solvent and refluxing for 2 hours to 24 hours; Wherein, the compound containing hydroxy diacid group is selected from any one of the following: The halogenated hydrocarbon has the formula Structure, wherein Z is selected from any one of F, Cl, Br, and I.

5. The method for preparing polybenzimidazole according to claim 2, characterized in that: The clear solution containing polyphosphoric acid further comprises phosphorus pentoxide, and the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15).

6. The method for preparing polybenzimidazole according to any one of claims 2 to 5, characterized in that: The solvent is selected from one or more of tetrahydrofuran, acetone, ethanol, acetonitrile, N-methylpyrrolidone, dimethyl sulfoxide, N'N-dimethylformamide and N,N-dimethylacetamide; and / or, The washing operation is performed using a saturated aqueous sodium bicarbonate solution, a saturated aqueous potassium carbonate solution, a saturated aqueous sodium carbonate solution or aqueous ammonia; and / or, The drying temperature is 80°C to 100°C; and / or, The protective gas is nitrogen.

7. The method for preparing polybenzimidazole according to claim 1, characterized in that: The steps include: S101: Under protective gas conditions, dissolving a tetraamine group-containing compound and a hydroxydiacid group-containing compound in a clear solution containing polyphosphoric acid at a molar ratio of 0.8 / 1 to 1 / 1.2, heating to 160° C. to 220° C. for reaction for 1 h to 48 h, then washing to neutrality, filtering and collecting the filter residue, and then drying to obtain a polybenzimidazole intermediate; S102: dissolving the polybenzimidazole intermediate and the halogenated hydrocarbon in a solvent, and refluxing for 2 h to 24 h to prepare polybenzimidazole; Wherein, the tetraamine group-containing compound is selected from Formula II': The compound containing hydroxy diacid groups is selected in whole or in part from any one of the following: The halogenated hydrocarbon has the formula Structure, wherein Z is selected from any one of F, Cl, Br, and I.

8. The method for preparing polybenzimidazole according to claim 7, characterized in that: The sum of the mass of the tetraamine group-containing compound and the hydroxydiacid group-containing compound accounts for 1% to 20% of the clear solution, and / or, the molar ratio of the tetraamine group-containing compound to the hydroxydiacid group-containing compound is (1.02:1) to (1:1.02); And / or, the clear solution containing polyphosphoric acid further comprises phosphorus pentoxide, and the mass ratio of the phosphorus pentoxide to the polyphosphoric acid is 1:(6-15).

9. The method for preparing polybenzimidazole according to claim 7, characterized in that: The solvent is selected from one or more of tetrahydrofuran, acetone, ethanol, acetonitrile, N-methylpyrrolidone, dimethyl sulfoxide, N'N-dimethylformamide and N,N-dimethylacetamide; and / or, in step S101, a saturated sodium bicarbonate aqueous solution, a saturated potassium carbonate aqueous solution, a saturated sodium carbonate aqueous solution or ammonia water is used for washing; And / or, in step S101, the drying temperature is 80°C to 100°C; And / or, in the step S101, the protective gas is nitrogen.

10. Application of the polybenzimidazole according to claim 1 and / or the preparation method of the polybenzimidazole according to any one of claims 2 to 9 in the fields of aerospace materials, semiconductor materials, fireproof and heat-resistant materials and fuel cells.